Status:
COMPLETED
The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble
Lead Sponsor:
Jason Hsu, MD
Conditions:
Scleral Buckling
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.
Detailed Description
A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration following Scleral Buckling and Pneumatic Retinopexy
Eligibility Criteria
Inclusion
- Ability to provide written informed consent and comply with study assessments for the full duration of the study.
- Have undergone eye surgery including scleral buckling or pneumatic retinopexy for treatment of retinal detachment other condition at the discretion of the investigator.
Exclusion
- Prior surgery to treat glaucoma.
- Current use of glaucoma eye drops.
- Absence of a lens in the eye or presence of a lens implant in front of the iris (colored part of your eye).
- Allergy or contraindication to any of the glaucoma drops being used in this study (e.g., sulfa allergy, asthma, chronic obstructive pulmonary disease (bronchitis or emphysema), slow heart rate).
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01843920
Start Date
June 1 2011
End Date
April 1 2013
Last Update
May 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mid Atlantic Retina- Wills Eye Institute
Philadelphia, Pennsylvania, United States, 19107